2021-03-24 14:03 |
Detailed record - Similar records
|
2020-09-07 14:28 |
Detailed record - Similar records
|
2020-08-26 15:39 |
Detailed record - Similar records
|
2020-08-26 13:13 |
Detailed record - Similar records
|
2020-08-26 13:07 |
[DZNE-2020-01027]
Abstract
Braun, H. ; Reymann, K.
Characterization of cerebral small vessel disease in SHRSP: A longitudinal MRI study at 3.0 Tesla
2013European Stroke Conference, LondonLondon, UK, 28 May 2013 - 31 May 20132013-05-282013-05-31
Background:Human cerebral small vessel disease (CSVD, cerebral microangiopathy) is one of the leading causes of vascular dementia and ischemic stroke and is caused by degenerative small vessel wall chang-es. In spontaneously hype1tensive stroke-prone rats (SHRSP), a wen-established animal model of.SVD, we recently showed that cerebral microangiopathy develops in distinct histopathologicall teps initiated by intracapillary and -arteriolar erythrocyte accumulations. [...]
External link: Fulltext
Detailed record - Similar records
|
2020-08-26 11:48 |
Detailed record - Similar records
|
2020-08-26 11:46 |
Detailed record - Similar records
|
2020-08-26 10:53 |
[DZNE-2020-01023]
Abstract/Journal Article
Shi, Y. ; Ulrich, J. ; Ising, C. ; et al
M159. Overexpression of Low-Density LipoproteinReceptor Markedly Reduces Tau Pho sphorylation andAttenuates Tau-Mediated Neurodegeneration via APOE-Mediated Mechanisms
2019144th Annual Meeting American Neurological Association, ANA 2019, St. Louis, MoSt. Louis, Mo, USA, 13 Oct 2019 - 15 Oct 20192019-10-132019-10-15
Annals of neurology 86(S24), S151 (2019)2019
APOE4 is the strongest genetic risk factor for late-onset Alz-heimer’s disease. While APOE influences brain amyloid-β(Aβ) pathology via affecting Aβ aggregation and clearance,recent findings reveal an Aβ-independent role of APOE inregulating tau-mediated neurodegeneration. [...]
External link: Fulltext
Detailed record - Similar records
|
2020-08-26 10:47 |
[DZNE-2020-01022]
Abstract/Journal Article
Schultz, S. ; Adedokun, A. ; Strain, J. ; et al
M148. Association between Serum Neurofilament Lightand Established White Matter Neuroimaging Markers inAutosomal Dominant Alzheimer Disease
2019144th Annual Meeting American Neurological Association, ANA 2019, St. Louis, MoSt. Louis, Mo, USA, 13 Oct 2019 - 15 Oct 20192019-10-132019-10-15
Annals of neurology 86(S23), S145 - S146 (2019)2019
Background: White matter (WM) alterations are a commonfeature of Alzheimer Disease (AD), typically detected in vivowith diffusion tensor imaging (DTI). Blood-based neurofila-ment light (NfL) is an emerging biomarker for monitoringneurodegeneration. [...]
External link: Fulltext
Detailed record - Similar records
|
2020-08-26 10:37 |
[DZNE-2020-01021]
Abstract/Journal Article
Yang, C. Y. ; Chanalaris, A. ; Scilabra, S. ; et al
Understanding the role of ADAM15 in osteoarthritis
2017British Society for Matrix Biology Spring 2017 Meeting: Matrix Proteoglycans: active participants in cell‐extracellular matrix communication, OxfordOxford, UK, 3 Apr 2017 - 4 Apr 20172017-04-032017-04-04
International journal of experimental pathology 98(3), A21-A22 (2017)2017
Introduction A disintegrin and metalloproteinase 15(ADAM15) is a member of the ADAM family of metallo-proteinases, which are functionally important enzymesinvolved in a wide variety of biological functions. A previ-ous study on Adam15-null mice demonstrated that malemice lacking ADAM15 developed accelerated age-relatedosteoarthritis (OA), suggesting that ADAM15 has chon-droprotective effects in OA. [...]
External link: Fulltext
Detailed record - Similar records
|
|
|